---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-344646"
form_type: "8-K"
ticker: "CDXS"
cik: "0001200375"
company_name: "CODEXIS, INC."
filed_at: "2026-08-11T20:11:09+00:00"
generated_at: "2026-08-11T20:12:18.329559+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Codexis Q2 revenue $14.9M, net loss $12.0M; reiterates FY guidance

## Summary
- Q2 2026 revenue $14.9M vs $15.3M YoY; net loss $12.0M ($0.13/sh) vs $13.3M ($0.16/sh).
- Product gross margin 73% vs 72% YoY; cash at June 30 was $54.9M.
- Completed July equity raise of ~$25M net proceeds; proforma cash ~$80M.
- Reiterated FY2026 revenue guidance of $72-76M; high 60% gross margin; cash runway through 2028.
- TIDES US data showed ECO Synthesis stereoisomer control for siRNA; GMP facility permit application planned H2 2026.

## SEC filing metadata
- accession: 0001193125-26-344646
- form_type: 8-K
- ticker: CDXS
- cik: 0001200375
- company_name: CODEXIS, INC.
- filed_at: 2026-08-11T20:11:09+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1200375/000119312526344646/0001193125-26-344646-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1200375/000119312526344646/d171403d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-344646
- JSON: https://secwatch.observer/filing/0001193125-26-344646.json
- Plain text: https://secwatch.observer/filing/0001193125-26-344646.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.